Castle Biosciences Pretax Profit Margin Over Time
| CSTL Stock | USD 30.28 0.16 0.53% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Castle Biosciences Performance and Castle Biosciences Correlation. Castle |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Castle Biosciences. If investors know Castle will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Castle Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.93) | Earnings Share 0.21 | Revenue Per Share 11.34 | Quarterly Revenue Growth 0.395 | Return On Assets (0) |
The market value of Castle Biosciences is measured differently than its book value, which is the value of Castle that is recorded on the company's balance sheet. Investors also form their own opinion of Castle Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Castle Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Castle Biosciences' market value can be influenced by many factors that don't directly affect Castle Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Castle Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Castle Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Castle Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Pretax Profit Margin Analysis
Compare Castle Biosciences and related stocks such as Caredx Inc, Twist Bioscience Corp, and Biodesix Pretax Profit Margin Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CDNA | (0.2474) | (0.2474) | (0.2474) | (0.1603) | (0.0263) | (0.487) | (1.018) | (1.1851) | (0.6297) | (0.1885) | (0.1028) | (0.1083) | (0.2369) | (0.6783) | (0.71) |
| TWST | (19.4306) | (19.4306) | (19.4306) | (19.4306) | (19.4306) | (19.4306) | (5.4825) | (2.7921) | (1.9744) | (1.5488) | (1.1639) | (1.1214) | (0.8301) | (0.6651) | (0.7) |
| BDSX | (1.2806) | (1.2806) | (1.2806) | (1.2806) | (1.2806) | (1.2806) | (1.2806) | (1.2806) | (1.2806) | (1.2515) | (0.6881) | (0.7918) | (1.7127) | (1.0623) | (1.12) |
| NTRA | (5.3453) | (5.3453) | (5.3453) | (0.6726) | (0.0323) | (0.3692) | (0.4405) | (0.6441) | (0.4961) | (0.4063) | (0.5873) | (0.7532) | (0.6667) | (0.4014) | (0.42) |
| FONR | (1.2115) | 0.1779 | 0.1624 | 0.1613 | 0.1856 | 0.1977 | 0.2475 | 0.2427 | 0.2583 | 0.1651 | 0.1964 | 0.2333 | 0.1598 | 0.1873 | 0.2 |
| XGN | (7.8639) | (7.8639) | (7.8639) | (4.4039) | (1.2856) | (1.0548) | (0.9766) | (0.9766) | (0.2452) | (0.2974) | (0.3994) | (0.5523) | (1.0462) | (0.4502) | (0.47) |
| PSNL | (2.5118) | (2.5118) | (2.5118) | (2.5118) | (2.5118) | (2.5118) | (2.5118) | (2.5118) | (0.5263) | (0.3845) | (0.5241) | (0.7628) | (1.7414) | (1.4727) | (1.55) |
| GH | (1.8271) | (1.8271) | (1.8271) | (1.8271) | (1.8271) | (1.8271) | (1.8271) | (1.6696) | (0.9292) | (0.3252) | (0.8576) | (1.0289) | (1.4536) | (0.849) | (0.89) |
| BNR | (1.1809) | (1.1809) | (1.1809) | (1.1809) | (1.1809) | (1.1809) | (1.1809) | (1.1809) | (0.8498) | (0.4432) | (0.9473) | (1.567) | (1.7208) | (1.2119) | (1.27) |
| SERA | (459) | (459) | (459) | (459) | (459) | (459) | (459) | (459) | (459) | (459) | (794) | (427) | (165) | (118) | (124) |
| STIM | (0.3282) | (0.3282) | (0.3282) | (0.3282) | (0.3282) | (0.3282) | (0.3282) | (0.3972) | (0.4566) | (0.4635) | (0.5575) | (0.5639) | (0.5699) | (0.4231) | (0.44) |
| ENZ | 0.2877 | (0.397) | (0.2022) | (0.1032) | (0.0235) | 0.4526 | (0.0225) | (0.109) | 0.0307 | (0.3752) | 0.0669 | (0.1706) | (0.8056) | (0.3077) | (0.29) |
Castle Biosciences and related stocks such as Caredx Inc, Twist Bioscience Corp, and Biodesix Pretax Profit Margin description
My Equities
My Current Equities and Potential Positions
| Castle Biosciences | CSTL |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Location | Texas; U.S.A |
| Exchange | NASDAQ Exchange |
USD 30.28
Check out Castle Biosciences Performance and Castle Biosciences Correlation. For more information on how to buy Castle Stock please use our How to buy in Castle Stock guide.You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Castle Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.